in this issue
Regions :: North America
Lonza Acquires U.S. Contract Manufacturer
11:42 PM MDT | August 30, 2010 | Deepti Ramesh
Lonza says it has entered the viral-based manufacturing market with its acquisition of Vivante GMP Solutions (Houston, TX). Vivante is a custom manufacturing organization producing viral-based therapeutics, and the acquisition advances Lonza’s strategy to broaden its biologics custom service offering for the growing viral vaccine and gene therapy markets, Lonza says. Financial terms of the acquisition were not disclosed. “Lonza is strategically committed to being successful in the growing viral marketplace,” says David Smith, head of Therapeutic...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee